It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BLFS’s FA Score shows that 1 FA rating(s) are green whileRMD’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BLFS’s TA Score shows that 4 TA indicator(s) are bullish while RMD’s TA Score has 6 bullish TA indicator(s).
BLFS (@Pharmaceuticals: Other) experienced а -1.18% price change this week, while RMD (@Pharmaceuticals: Other) price change was +2.06% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was -1.97%, and the average quarterly price growth was +23.00%.
BLFS is expected to report earnings on Mar 12, 2026.
RMD is expected to report earnings on Apr 23, 2026.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| BLFS | RMD | BLFS / RMD | |
| Capitalization | 1.09B | 38.3B | 3% |
| EBITDA | -14.25M | 2B | -1% |
| Gain YTD | -6.245 | 9.200 | -68% |
| P/E Ratio | N/A | 26.02 | - |
| Revenue | 100M | 5.26B | 2% |
| Total Cash | 79M | 1.38B | 6% |
| Total Debt | 20.7M | 846M | 2% |
BLFS | RMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 6 | 14 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 37 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 76 | |
SMR RATING 1..100 | 90 | 36 | |
PRICE GROWTH RATING 1..100 | 62 | 57 | |
P/E GROWTH RATING 1..100 | 15 | 62 | |
SEASONALITY SCORE 1..100 | 90 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RMD's Valuation (37) in the Medical Specialties industry is somewhat better than the same rating for BLFS (99). This means that RMD’s stock grew somewhat faster than BLFS’s over the last 12 months.
RMD's Profit vs Risk Rating (76) in the Medical Specialties industry is in the same range as BLFS (100). This means that RMD’s stock grew similarly to BLFS’s over the last 12 months.
RMD's SMR Rating (36) in the Medical Specialties industry is somewhat better than the same rating for BLFS (90). This means that RMD’s stock grew somewhat faster than BLFS’s over the last 12 months.
RMD's Price Growth Rating (57) in the Medical Specialties industry is in the same range as BLFS (62). This means that RMD’s stock grew similarly to BLFS’s over the last 12 months.
BLFS's P/E Growth Rating (15) in the Medical Specialties industry is somewhat better than the same rating for RMD (62). This means that BLFS’s stock grew somewhat faster than RMD’s over the last 12 months.
| BLFS | RMD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 83% | 1 day ago 61% |
| Stochastic ODDS (%) | 1 day ago 79% | 1 day ago 57% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 64% |
| MACD ODDS (%) | 1 day ago 88% | 1 day ago 54% |
| TrendWeek ODDS (%) | 1 day ago 85% | 1 day ago 61% |
| TrendMonth ODDS (%) | 1 day ago 85% | 1 day ago 61% |
| Advances ODDS (%) | 3 days ago 75% | 9 days ago 62% |
| Declines ODDS (%) | 7 days ago 85% | 3 days ago 59% |
| BollingerBands ODDS (%) | 1 day ago 88% | 1 day ago 59% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 66% |
A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.
| Ticker / NAME | Correlation To BLFS | 1D Price Change % | ||
|---|---|---|---|---|
| BLFS | 100% | -0.74% | ||
| RGEN - BLFS | 56% Loosely correlated | -2.74% | ||
| SMTI - BLFS | 52% Loosely correlated | +0.92% | ||
| RVTY - BLFS | 51% Loosely correlated | +2.67% | ||
| A - BLFS | 50% Loosely correlated | +0.64% | ||
| AZTA - BLFS | 47% Loosely correlated | -22.81% | ||
More | ||||
A.I.dvisor indicates that over the last year, RMD has been loosely correlated with BLFS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then BLFS could also see price increases.
| Ticker / NAME | Correlation To RMD | 1D Price Change % | ||
|---|---|---|---|---|
| RMD | 100% | +4.62% | ||
| BLFS - RMD | 44% Loosely correlated | -0.74% | ||
| SMTI - RMD | 43% Loosely correlated | +0.92% | ||
| SOLV - RMD | 40% Loosely correlated | +0.98% | ||
| RVTY - RMD | 40% Loosely correlated | +2.67% | ||
| SYK - RMD | 39% Loosely correlated | -0.04% | ||
More | ||||